Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom  Christiansen; Lykke Midtbøll Ørnbjerg; Simon Horskjær Rasmussen; AG Loft; Merete Lund Hetland; Mikkel Østergaard

Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, AG Loft, Merete Lund Hetland, Mikkel Østergaard

Center for Rheumatology and Spine Diseases

Original language	English
Article number	PP20
Book series	Scandinavian Journal of Rheumatology, Supplement
Volume	50
Issue number	130
Pages (from-to)	31-2
Number of pages	2
ISSN	0301-3847
Publication status	Published - 2021

Cite this

Christiansen, S. N., Ørnbjerg, L. M., Rasmussen, S. H., Loft, AG., Hetland, M. L., & Østergaard, M. (2021). Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. Scandinavian Journal of Rheumatology, Supplement, 50(130), 31-2. [PP20].

Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. / Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll ; Rasmussen, Simon Horskjær et al.

In: Scandinavian Journal of Rheumatology, Supplement, Vol. 50, No. 130, PP20, 2021, p. 31-2.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Christiansen, SN , Ørnbjerg, LM , Rasmussen, SH, Loft, AG, Hetland, ML & Østergaard, M 2021, 'Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration', Scandinavian Journal of Rheumatology, Supplement, vol. 50, no. 130, PP20, pp. 31-2.

Christiansen SN , Ørnbjerg LM , Rasmussen SH, Loft AG, Hetland ML , Østergaard M. Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. Scandinavian Journal of Rheumatology, Supplement. 2021;50(130):31-2. PP20.

Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll ; Rasmussen, Simon Horskjær et al. / Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. In: Scandinavian Journal of Rheumatology, Supplement. 2021 ; Vol. 50, No. 130. pp. 31-2.

@article{49ff79683d874c65a52a1a7bb41e6628,

title = "Secular trends in baseline characteristics, treatment retention and response rates in 17 453 biona{\"i}ve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration",

author = "Christiansen, {Sara Nysom} and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Rasmussen, {Simon Horskj{\ae}r} and AG Loft and Hetland, {Merete Lund} and Mikkel {\O}stergaard",

note = "COPECARE",

year = "2021",

language = "English",

volume = "50",

pages = "31--2",

journal = "Scandinavian Journal of Rheumatology, Supplement",

issn = "0301-3847",

publisher = "Taylor & Francis A B",

number = "130",

}

TY - ABST

T1 - Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

AU - Christiansen, Sara Nysom

AU - Ørnbjerg, Lykke Midtbøll

AU - Rasmussen, Simon Horskjær

AU - Loft, AG

AU - Hetland, Merete Lund

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

VL - 50

SP - 31

EP - 32

JO - Scandinavian Journal of Rheumatology, Supplement

JF - Scandinavian Journal of Rheumatology, Supplement

SN - 0301-3847

IS - 130

M1 - PP20

ER -